Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · January 17, 2024

Outcomes of Using Azathioprine vs Mycophenolate Mofetil for the Induction of Remission in Treatment-Naïve Patients With Autoimmune Hepatitis

Journal of Hepatology


Additional Info

Journal of Hepatology
An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis
J. Hepatol. 2023 Dec 13;[EPub Ahead of Print], RJALM Snijders, AEC Stoelinga, TJG Gevers, S Pape, M Biewenga, ME Tushuizen, RC Verdonk, HJM de Jonge, JM Vrolijk, SF Bakker, T Vanwolleghem, YS de Boer, MAMC Baven Pronk, U Beuers, AJ van der Meer, NMFV Gerven, MGM Sijtsma, BC van Eijck, MC van IJzendoorn, M van Herwaarden, FF van den Brand, KS Korkmaz, AP van den Berg, MMJ Guichelaar, AD Levens, B van Hoek, JPH Drenth

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading